Latest Product Development News

InteliCare successfully completed its largest aged care pilot at mecwacare’s Trescowthick Centre and secured $2 million in funding, while navigating a key leadership transition.

InteliCare Holdings reported a $834,000 operating cash outflow for Q3 2025 but bolstered its balance sheet with a $1.8 million capital raise, positioning itself to sustain operations over the coming quarters.

Thrive Tribe Technologies reported a $451,000 net operating cash outflow in Q1 FY26 but bolstered its cash reserves to $589,000 through over $1 million in equity placements. The company progressed its Thrive Tribe Home Base initiative and expanded its digital business units while managing a limited cash runway.

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.

Oakridge International reports robust Q1 2025 results with strong sales and technology advances, while managing a potential legal claim.

WA Kaolin Ltd has reported a record-breaking quarter in sales volume and revenue, driven by operational enhancements and expanding market reach across Asia and domestic sectors.

McPherson’s Limited updates shareholders on its ongoing transformation journey, reporting modest core brand growth in FY25 and outlining a strategic outlook for FY26 focused on sustainable expansion and operational efficiency.

Spenda Limited reported a record $204 million in payment volumes for Q1 FY26 alongside a strategic cost reduction of 21% annualised. The quarter also saw a significant leadership change with the resignation of its Managing Director.

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

Electro Optic Systems (EOS) reports a surge in contract backlog to $415 million, anchored by a landmark $125 million export order for a high-energy laser weapon. Despite a $34.3 million operating cash outflow in Q3, EOS is poised for growth with new defence contracts and product innovations.

HALO Technologies reports a 17% rise in quarterly revenue, driven by a surge in brokerage income and a strategic launch of Managed Funds in Australia, supported by a recent $3.9 million rights issue.